Author

A. Dirlam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

G. Vavouras Syrigos· 1 shared I. Gruska· 1 shared K. Hamprecht· 1 shared L. Wiebusch· 1 shared M. Feige· 1 shared M. Schindler· 1 shared R. Businger· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

G. Vavouras Syrigos

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1

G. Vavouras Syrigos, M. Feige, A. Dirlam, R. Businger, I. Gruska, L. Wiebusch, K. Hamprecht, M. Schindler

This study shows that Abemaciclib inhibits HCMV replication by blocking pUL97-mediated SAMHD1 phosphorylation, establishing SAMHD1 as a therapeutic target.

bioRxiv · Feb 1, 2023Microbiology